Publications and Further Research Outputs
Peer-Reviewed Publications
D.S. BORDIN, Yu.V. EMBUTNIEKS, L.G. VOLOGZHANINA, T.A. IL'CHISHINA, I.N. VOINOVAN, A.S. SARSENBAEVA, S.A. ALEKSEENKO, O.V. ZAITSEV, R.A. ABDULKHAKOV, M.F. OSIPENKO, M.A. LIVZAN, V.V. TSUKANOV, S.G. BURKOV, N.V. BAKULINA, N.N. DEKHNICH, L.V. TARASOVA, E.Yu. PLOTNIKOVA, I.V. MAEV, Yu.A. KUCHERYAVYI, N.V. BARYSHNIKOVA, M.A. BUTOV, S.V. KOLBASNIKOV, A.L. PAKHOMOVA, T.V. ZHESTKOVA, A.Yu. BARANOVSKII, S.R. ABDULKHAKOV, E.A. AGEEVA, E.A. LYALYUKOVA, A.V. VASYUTIN, N.N. GOLUBEV, I.V. SAVILOVA, L.V. MORKOVKINA, A.G. KONONOVA, F. MEGRAUD, C. O'MORAIN, M. RAMAS, O.P. NYSSEN, A.G. MCNICHOLL, J.P. GISBERT on behalf of the scientific Committee and researchers Hp-EuReg , Европейский регистр Helicobacter pylori (Hp-EuReg): анализ данных 2360 больных, получавших терапию первой линии в России | European Registry on the management of Helicobacter pylori infection (Hp-EuReg): an analysis of 2360 patients receiving first-line therapy in Russia, Terapevticheskii Arkhiv, 92, (2), 2020, p12 - 18
Smith SM, O'Morain C, McNamara D, Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance., World journal of gastroenterology, 20, (29), 2014, p9912-21
Söderman J, Norén E, Christiansson M, Bragde H, Thiébaut R, Hugot JP, Tysk C, O'Morain CA, Gassull M, Finkel Y, Colombel JF, Lémann M, Almer S, Analysis of single nucleotide polymorphisms in the region of CLDN2-MORC4 in relation to inflammatory bowel disease., World journal of gastroenterology : WJG, 19, (30), 2013, p4935-43
Shuhaibar M, Walsh C, Lindsay F, Lee N, Walsh P, O'Gorman P, Boran G, McLoughlin R, Qasim A, Breslin N, Ryan B, O'Connor H, O'Morain C, A comparative study of faecal occult blood kits in a colorectal cancer screening program in a cohort of healthy construction workers., Irish journal of medical science, 180, (1), 2011, p103-8
Anthony O'Connor, Javier P. Gisbert, Deirdre McNamara, Colm O'Morain, Treatment of Helicobacter pylori Infection 2011, Helicobacter, 16, (s1), 2011, p53-58
Momozawa Y, Mni M, Nakamura K, Coppieters W, Almer S, Amininejad L, Cleynen I, Colombel JF, de Rijk P, Dewit O, Finkel Y, Gassull MA, Goossens D, Laukens D, Lémann M, Libioulle C, O'Morain C, Reenaers C, Rutgeerts P, Tysk C, Zelenika D, Lathrop M, Del-Favero J, Hugot JP, de Vos M, Franchimont D, Vermeire S, Louis E, Georges M, Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease., Nature genetics, 43, (1), 2011, p43-7
O'Morain CA, Van Cutsem E, Spicak J, Classen M, Faulds Wood L, Stockbrugger R, European initiatives in colorectal cancer screening., European journal of gastroenterology & hepatology, 23, (3), 2011, p201-3
McNamara D, Qasim A, Lee N, Condon C, O'Morain C, Round one of the Adelaide and Meath Hospital/Trinity College Colorectal Cancer Screening Programme: programme report and analysis based on established international key performance indices., Irish journal of medical science, 180, (2), 2011, p549 - 542
Malfertheiner P, Bazzoli F, Delchier JC, Celiñski K, Giguère M, Rivière M, Mégraud F, Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial., Lancet, 377, (9769), 2011, p905-13
Brophy K*, Ryan AW*, Turner G, Trimble V, Patel KD, O'Morain C, Kennedy NP, Egan B, Close E, Lawlor G, MacMathuna P, Stevens FM, Abuzakouk M, Feighery C, Kelleher D, McManus R, Evaluation of 6 candidate genes on chromosome 11q23 for coeliac disease susceptibility: a case control study, BMC Medical Genetics, 11, (76), 2010
Elkjaer M, Shuhaibar M, Burisch J, Bailey Y, Scherfig H, Laugesen B, Avnstrøm S, Langholz E, O'Morain C, Lynge E, Munkholm P, E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach., Gut, 59, (12), 2010, p1652-61
O'Connor A, Keane RA, Egan B, Lee N, O'Connor H, Qasim A, Ryan B, Breslin N, McNamara D, O'Morain C, Adherence to colorectal polyp surveillance guidelines: is there scope to increase the opportunities for screening?, European Journal of Cancer Prevention : the official journal of the European Cancer Prevention Organisation (ECP), 20, (1), 2010, p40 - 45
Qasim, A, O'morain, C, Primary prevention of colorectal cancer: are we closer to reality?, European journal of gastroenterology & hepatology, 22, (1), 2010, p9 - 17
Odes S, Vardi H, Friger M, Esser D, Wolters F, Moum B, Waters H, Elkjaer M, Bernklev T, Tsianos E, O'Morain C, Stockbrügger R, Munkholm P, Langholz E, Clinical and economic outcomes in a population-based European cohort of 948 ulcerative colitis and Crohn's disease patients by Markov analysis., Alimentary pharmacology & therapeutics, 31, (7), 2010, p735-44
Kelly OB, O'Donnell S, O'Moráin CA, A case of achalasia diagnosed first on capsule endoscopy: find that hard to swallow?, European journal of gastroenterology & hepatology, 22, (8), 2010, p1013-4
O'connor A, Taneike I, Nami A, Fitzgerald N, Murphy P, Ryan B, O'connor H, Qasim A, Breslin N, O'moráin C, Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland., European journal of gastroenterology & hepatology, 22, (9), 2010, p1123-7
Thiébaut R, Douchin V, Jung C, Merlin F, Colombel JF, Lemann M, Almer S, Tysk C, O'Morain C, Gassull M, Finkel Y, Zouali H, Pascoe L, Hugot JP, RIP2 polymorphisms in inflammatory bowel diseases., Inflammatory bowel diseases, 17, (4), 2010, p1055 - 1055
O'Connor JP, O'Moráin CA, Vargo JJ, Computer-assisted propofol administration., Digestion, 82, (2), 2010, p124-6
Russo, EA, Iacucci, M, Lindsay, JO, Campbell, S, Hart, A, Hamlin, J, Orchard, T, Arebi, N, Nightingale, J, Jacyna, MR, Gabe, SM, O"connor, M, Harris, AW, O"morain, C, Ghosh, S, Survey on the use of adalimumab as maintenance therapy in Crohn's disease in England and Ireland., European journal of gastroenterology & hepatology, 22, (3), 2010, p334 - 339
Qasim A, Ryan B, Breslin N, O'Morain C, Gastric retention and wireless capsule endoscopy in adults: a modified technique for direct duodenal deployment., Gut, 59, (7), 2010, p1004-5
Russo, Evangelos A; Iacucci, Marietta; Lindsay, James O; Campbell, Simon; Hart, Ailsa; Hamlin, John; Orchard, Timothy; Arebi, Maila; Nightingale, Jeremy; Jacyna, Meron R; Gabe, Simon M; O'Connor, Marian; Harris, Adrian W; O'Morain, Colm; Ghosh, Subrata, Survey on the use of adalimumab as maintenance therapy in Crohn's disease in England and Ireland, European Journal of Gastroenterology & Hepatology, 22, (3), 2010, p334 - 339
O'Connor A, Gisbert JP, McNamara D, O'Morain C, Treatment of Helicobacter pylori infection 2010., Helicobacter, 15 Suppl 1, 2010, p46-52
Gisbert JP, Calvet X, O'Connor JP, Mégraud F, O'Morain CA, The sequential therapy regimen for Helicobacter pylori eradication., Expert opinion on pharmacotherapy, 11, (6), 2010, p905-18
Gisbert JP, Calvet X, O'Connor A, Mégraud F, O'Morain CA, Sequential therapy for Helicobacter pylori eradication: a critical review., Journal of clinical gastroenterology, 44, (5), 2010, p313-25
Brophy K, Ryan AW, Turner G, Trimble V, Patel KD, O'Morain C, Kennedy NP, Egan B, Close E, Lawlor G, MacMathuna P, Stevens FM, Abuzakouk M, Feighery C, Kelleher D, McManus R, Evaluation of 6 candidate genes on chromosome 11q23 for coeliac disease susceptibility: a case control study., BMC medical genetics, 11, 2010, p76
Hughes D, Hlavatá I, Soucek P, Pardini B, Naccarati A, Vodickova L, O'Morain C, Vodicka P, Ornithine Decarboxylase G316A Genotype and Colorectal Cancer Risk., Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2010
Qasim, A, O'Morain, CA, O'Connor, HJ, Helicobacter pylori eradication: role of individual therapy constituents and therapy duration., Fundamental & clinical pharmacology, 23, (1), 2009, p43 - 52
Taneike, I, Nami, A, O'Connor, A, Fitzgerald, N, Murphy, P, Qasim, A, O'Connor, H, O'Morain, C, Analysis of drug resistance and virulence-factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status?, Alimentary pharmacology & therapeutics, 30, (7), 2009, p784 - 790
Veerappan, SG, O'Morain, CA, Infliximab-associated alveolitis after treatment for severe left-sided ulcerative colitis., European journal of gastroenterology & hepatology, 21, (7), 2009, p830 - 832
Milne, AN, Carneiro, F, O'Morain, C, Offerhaus, GJ, Nature meets nurture: molecular genetics of gastric cancer., Human genetics, 126, (5), 2009, p615 - 628
Canacan JB, Bennett K, Feely J, O'Morain CA, O'Connor HJ, Significant psychological morbidity occurs in irritable bowel syndrome: a case-control study using a pharmacy reimbursement, Alimentary Pharmacology and Therapeutics, 29, (4), 2009, p440 - 449
Felley C, Vader JP, Juillerat P, Pittet V, O'Morain C, Panis Y, Vucelic B, Gonvers JJ, Mottet C, Froehlich F, Michetti P, Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT II., Journal of Crohn's & colitis, 3, (4), 2009, p250-256
O'Morain, CA, O'Connor, JP, Is sequential therapy superior to standard triple therapy for the treatment of Helicobacter pylori infection?, Nature clinical practice. Gastroenterology & hepatology, 6, (1), 2009, p8 - 9
Saleem, A, Qasim, A, O'Connor, HJ, O'Morain, CA, Pylera for the eradication of Helicobacter pylori infection., Expert review of anti-infective therapy, 7, (7), 2009, p793 - 799
Murphy, G, Thornton, J, McManus, R, Swan, N, Ryan, B, Hughes, DJ, O'Morain, CA, O'Sullivan, M, Association of gastric disease with polymorphisms in the inflammatory-related genes IL-1B, IL-1RN, IL-10, TNF and TLR4., European journal of gastroenterology & hepatology, 21, (6), 2009, p630 - 635
O'Connor, A, Gisbert, J, O'Morain, C, Treatment of Helicobacter pylori infection., Helicobacter, 14 , (Suppl 1), 2009, p46 - 51
Suzuki H, Fukuda Y, Koizuka H, Tomita T, Hori K, Suzuki M, O'Morain C, Dietary Antigens in Crohn's Disease: Antibodies to Porcine Pancreatic Amylase, American Journal of Gastroenterology, 103, (3), 2008, p656 - 664
O'Donnell S, O'Morain C, Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception., Alimentary Pharmacology & Therapeutics, 27, (10), 2008, p885 - 894
O'Sullivan M, Nic Suibhne T, Cox G, Healy M, O'Morain C, High prevalence of vitamin D insufficiency in healthy Irish adults., Irish journal of medical science, 177, (2), 2008, p131-4
Hunt KA, Zhernakova A, Turner G, Heap GA, Franke L, Bruinenberg M, Romanos J, Dinesen LC, Ryan AW, Panesar D, Gwilliam R, Takeuchi F, McLaren WM, Holmes GK, Howdle PD, Walters JR, Sanders DS, Playford RJ, Trynka G, Mulder CJ, Mearin ML, Verbeek WH, Trimble V, Stevens FM, O'Morain C, Kennedy NP, Kelleher D, Pennington DJ, Strachan DP, McArdle WL, Mein CA, Wapenaar MC, Deloukas P, McGinnis R, McManus R, Wijmenga C, van Heel DA., Newly identified genetic risk variants for celiac disease related to the immune response, Nature Genetetics, 40, (4), 2008, p395 - 402
Veerappan, SG, Moinuddin, G, Kennedy, M, O'Morain, CA, Kane, D, Early diagnosis of bilateral sub-deltoid bursitis using clinic-based ultrasonography in a patient receiving infliximab therapy for ulcerative pouchitis., Irish journal of medical science, 179, (4), 2008, p597-8
O'Donnell, S, Swan, N, Crotty, P, Sangster, D, O'Morain, C, Assessment of the clinical significance of intestinal spirochaetosis., Journal of clinical pathology, 61, (9), 2008, p1029 - 1033
O'Donnell S, O'Morain C, Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception., Alimentary pharmacology & therapeutics, 27, (10), 2008, p885-94
Hunt KA, Zhernakova A, Turner G, Heap GA, Franke L, Bruinenberg M, Romanos J, Dinesen LC, Ryan AW, Panesar D, Gwilliam R, Takeuchi F, McLaren WM, Holmes GK, Howdle PD, Walters JR, Sanders DS, Playford RJ, Trynka G, Mulder CJ, Mearin ML, Verbeek WH, Trimble V, Stevens FM, O'Morain C, Kennedy NP, Kelleher D, Pennington DJ, Strachan DP, McArdle WL, Mein CA, Wapenaar MC, Deloukas P, McGinnis R, McManus R, Wijmenga C, van Heel DA, Newly identified genetic risk variants for celiac disease related to the immune response., Nature genetics, 40, (4), 2008, p395-402
Veerpan SG, Kennedy M, O'Morain CA, Ryan BM, Retinal vein thrombosis following infliximab treatment for severe left-sided ulcerative colitis, European Journal of Gastroenterolgy and Hepatology, 20, (6), 2008, p588 - 589
O'Sullivan M, Nic Suibhne T, Cox G, Healy M, O'Morain C, High prevalence of vitamin D insufficiency in healthy Irish adults, Irish Journal of Medical Science, 177, (2), 2008, p131 - 134
Suzuki H, Fukuda Y, Koizuka H, Tomita T, Hori K, Suzuki M, O'Morain C, Dietary antigens in Crohn's disease: antibodies to porcine pancreatic amylase., The American journal of gastroenterology, 103, (3), 2008, p656-64
O'Donnell S, O'Morain C, Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception., Alimentary Pharmacology & Therapeutics, 27, (10), 2008, p885 - 894
Cole SR, Hernán MA, Constructing inverse probability weights for marginal structural models., American journal of epidemiology, 168, (6), 2008, p656-64
Egan, BJ, O'Connor, HJ, O'Morain, CA, What is new in the management of Helicobacter pylori?, Irish journal of medical science, 177, (3), 2008, p185 - 188
Hunt KA, Zhernakova A, Turner G, Heap GA, Franke L, Bruinenberg M, Romanos J, Dinesen LC, Ryan AW, Panesar D, Gwilliam R,Takeuchi F, McLaren WM, Holmes GK, Howdle PD, Walters JR, Sanders DS, Playford RJ, Trynka G, Mulder CJ, Mearin ML,Verbeek WH, Trimble V, Stevens FM, O'Morain C, Kennedy NP, Kelleher D, Pennington DJ, Strachan DP, McArdle WL, Mein CA,Wapenaar MC, Deloukas P, McGinnis R, McManus R*, Wijmenga C*, van Heel DA*., Newly identified genetic risk variants for celiac disease related to the immune response., Nature Genetics, 40, 2008, p395-402
Egan, BJ, Marzio, L, O'Connor, H, O'Morain, C, Treatment of Helicobacter pylori infection., Helicobacter, 13, (1), 2008, p46 - 51
Qasim A, McDonald S, Sebastian S, McLoughlin R, Buckley M, O'Connor H, O'Morain C., Efficacy and safety of 6-thioguanine in the management of inflammatory bowel disease., Scandinavian Journal Gastroenterol., 42, (2), 2007, 194-9.
Malfertheiner P, Megraud F, O'morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ., Current concepts in the management of Helicobacter pylori infection - The Maastricht III Consensus Report., Gut. , 17, 2007, p772 - 781
Egan BJ, O'Morain CA, A historical perspective of Helicobacter gastroduodenitis and its complications., Best practice & research. Clinical gastroenterology, 21, (2), 2007, p335-46
Malik M, Tobin AM, Shanahan F, O'Morain C, Kirby B, Bourke J, Steroid allergy in patients with inflammatory bowel disease., The British journal of dermatology, 157, (5), 2007, p967-9
Egan BJ, Holmes K, O'Connor HJ, O'Morain CA, Helicobacter pylori gastritis, the unifying concept for gastric diseases., Helicobacter, 12 Suppl 2, 2007, p39-44
Egan BJ, O'Morain CA., A historical perspective of Helicobacter gastroduodenitis and its complications., Best Practice & Research. Clinical Gastroenterolgoy, 21, (2), 2007, p335 - 346
Wolters FL, Joling C, Russel MG, Sijbrandij J, De Bruin M, Odes S, Riis L, Munkholm P, Bodini P, Ryan B, O'Morain C, Mouzas IA, Tsianos E, Vermeire S, Monteiro E, Limonard C, Vatn M, Fornaciari G, Rodriguez D, Groot W, Moum B, Stockbrugger RW; European Collaborative Study Group On Inflammatory Bowel Disease (EC-IBD)., Treatment inferred disease severity in Crohn's disease: evidence for a European gradient of disease course., Scandinavian Journal Gastroenterology, 42, (3), 2007, p333-44.
Egan BJ, Katicic M, O'Connor HJ, O'Morain CA, Treatment of Helicobacter pylori., Helicobacter, 12 Suppl 1, 2007, p31-7
Ladas SD, Novis B, Triantafyllou K, Schoefl R, Rokkas T, Stanciu C, Isaacs P, Willich SN, Ronn O, Dremel H, Livadas G, Egan BJ, Boyacioglu S, Selimovic A, Pulanic R, Karagiannis JA, Van Vooren JP, Kouroumalis E, O'Morain C, Nowak A, Deviere J, Malfertheiner P, Axon A., Ethical issues in endoscopy: patient satisfaction, safety in elderly patients, palliation, and relations with industry. Second European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, July 2006., Endoscopy, 39, (6), 2007, p556-65
Sarwar S, Anwar MM, Ryan B, O'Morain C., Colonoscopy completion rates--are we prepared for a national screening programme?, Irish Medicial Journal, Oct;100 , (9), 2007, p585-7.
Odes S, Friger M, Vardi H, Claessens G, Bossuyt X, Riis L, Munkholm P, Wolters F, Yona H, Hoie O, Beltrami M, Tsianos E, Katsanos K, Mouzas I, Clofent J, Monteiro E, Messori A, Politi P, O'Morain C, Limonard C, Russel M, Vatn M, Moum B, Stockbrugger R, Vermeire S, Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: a project of the European Collaborative Study Group on Inflammatory Bowel Disease., Inflammatory bowel diseases, 13, (7), 2007, p874-81
Wolters FL, Joling C, Russel MG, Sijbrandij J, De Bruin M, Odes S, Riis L, Munkholm P, Bodini P, Ryan B, O'Morain C, Mouzas IA, Tsianos E, Vermeire S, Monteiro E, Limonard C, Vatn M, Fornaciari G, Rodriguez D, Groot W, Moum B, Stockbrügger RW, Treatment inferred disease severity in Crohn's disease: evidence for a European gradient of disease course., Scandinavian journal of gastroenterology, 42, (3), 2007, p333-44
Heetun ZS, Byrnes C, Neary P, O'Morain C, Review article: Reproduction in the patient with inflammatory bowel disease, Alimentary Pharmacology and Therapeutics, 26, (4), 2007, p513-533
Qasim, A, McDonald, S, Sebastian, S, McLoughlin, R, Buckley, M, O'Connor, H, O'Morain, C, Efficacy and safety of 6-thioguanine in the management of inflammatory bowel disease., Scandinavian Journal of Gastroenterology, 42, (2), 2007, p194-199
Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ, Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report., Gut, 56, (6), 2007, p772-81
Ladas SD, Novis B, Triantafyllou K, Schoefl R, Rokkas T, Stanciu C, Isaacs P, Willich SN, Ronn O, Dremel H, Livadas G, Egan BJ, Boyacioglu S, Selimovic A, Pulanic R, Karagiannis JA, Van Vooren JP, Kouroumalis E, O'Morain C, Nowak A, Deviere J, Malfertheiner P, Axon A, Ethical issues in endoscopy: patient satisfaction, safety in elderly patients, palliation, and relations with industry. Second European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, July 2006., Endoscopy, 39, (6), 2007, p556-65
Malik M, Tobin AM, Shanahan F, O'Morain C, Kirby B, Bourke J., Steroid allergy in patients with inflammatory bowel disease, British Journal of Dermatology, 157, (5), 2007, p967-9
Odes S, Friger M, Vardi H, Claessens G, Bossuyt X, Riis L, Munkholm P, Wolters F, Yona H, Hoie O, Beltrami M, Tsianos E, Katsanos K, Mouzas I, Clofent J, Monteiro E, Messori A, Politi P, O'morain C, Limonard C, Russel M, Vatn M, Moum B, Stockbrugger R, Vermeire S. , Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: A project of the European Collaborative Study Group on Inflammatory Bowel Disease., Inflammatory Bowel Disease, 2, 2007, p874 - 881
Egan BJ, Katicic M, O'Connor HJ, O'Morain CA, Treatment of Helicobacter pylori, Helicobacter, Oct;12 , (Suppl 1), 2007, p1:31-7
Sarwar S, Anwar MM, Ryan B, O'Morain C, Colonoscopy completion rates--are we prepared for a national screening programme?, Irish medical journal, 100, (9), 2007, p585-7
Ladas SD, Novis B, Triantafyllou K, Schoefl R, Rokkas T, Stanciu C, Isaacs P, Willich SN, Ronn O, Dremel H, Livadas G, Egan BJ, Boyacioglu S, Selimovic A, Pulanic R, Karagiannis JA, Van Vooren JP, Kouroumalis E, O'Morain C, Nowak A, Deviere J, Malfertheiner P, Axon A., Ethical issues in endoscopy: patient satisfaction, safety in elderly patients, palliation, and relations with industry. Second European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, July 2006., Endoscopy, 39, (6), 2007, p556-65
Heetun ZS, Byrnes C, Neary P, O'Morain C, Review article: Reproduction in the patient with inflammatory bowel disease., Alimentary pharmacology & therapeutics, 26, (4), 2007, p513-33
Riis L, Vind I, Vermeire S, Wolters F, Katsanos K, Politi P, Freitas J, Mouzas IA, O'Morain C, Ruiz-Ochoa V, Odes S, Binder V, Munkholm P, Moum B, Stockbrugger R, Langholz E; European Collaborative Study Group on Inflammatory Bowel Disease., The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients., Inflammatory Bowel Disease , 13, (1), 2007, 24-32.
Holmes K, Egan B, Swan N, O'Morain C, Genetic Mechanisms and Aberrant Gene Expression during the Development of Gastric Intestinal Metaplasia and Adenocarcinoma., Current genomics, 8, (6), 2007, p379-97
Egan BJ, Holmes K, O'Connor HJ, O'Morain CA., Helicobacter pylori gastritis, the unifying concept for gastric diseases, Helicobacter, 12, (2), 2007, p2:39-44
Riis L, Vind I, Vermeire S, Wolters F, Katsanos K, Politi P, Freitas J, Mouzas IA, O'Morain C, Ruiz-Ochoa V, Odes S, Binder V, Munkholm P, Moum B, Stockbrügger R, Langholz E, The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients., Inflammatory bowel diseases, 13, (1), 2007, p24-32
Odes S, Vardi H, Friger M, Wolters F, Russel MG, Riis L, Munkholm P, Politi P, Tsianos E, Clofent J, Vermeire S, Monteiro E, Mouzas I, Fornaciari G, Sijbrandij J, Limonard C, Van Zeijl G, O'morain C, Moum B, Vatn M, Stockbrugger R; European Collaborative Study on Inflammatory Bowel Disease., Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. , Gastroenterology, 131, (3), 2006, p719-28
Riis L, Vind I, Politi P, Wolters F, Vermeire S, Tsianos E, Freitas J, Mouzas I, Ruiz Ochoa V, O'Morain C, Odes S, Binder V, Moum B, Stockbrügger R, Langholz E, Munkholm P, Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease., The American journal of gastroenterology, 101, (7), 2006, p1539-45
Cavallaro LG, Egan B, O'Morain C, Di Mario F., Treatment of Helicobacter pylori infection., Helicobacter, 11, (Suppl 1), 2006, p36-9
Bennett K, Feely J, Thornton O, Dobson M, O'Morain CA, O'Connor HJ., Impact of Helicobacter pylori on the management of dyspepsia in primary care., Alimentary Pharmacology Therapeutics , 15;, (24(4)), 2006, p637-41
Bennett K, Feely J, Thornton O, Dobson M, O'Morain CA, O'Connor HJ, Impact of Helicobacter pylori on the management of dyspepsia in primary care., Alimentary pharmacology & therapeutics, 24, (4), 2006, p637-41
Wolters FL, Russel MG, Sijbrandij J, Schouten LJ, Odes S, Riis L, Munkholm P, Bodini P, O'Morain C, Mouzas IA, Tsianos E, Vermeire S, Monteiro E, Limonard C, Vatn M, Fornaciari G, Pereira S, Moum B, Stockbrugger RW, Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort, Gut, 55, (4), 2006, p510 - 518
Walshe V, O'Morain C, Bennett K, Keeling PW, Barry M, Best practice' for Helicobacter pylori eradication in the primary care setting, Irish Medical Journal, 99, (1), 2006, p11 - 12
O'Morain C., Role of Helicobacter pylori in functional dyspepsia., World J Gastroenterol., May 7, (12(17)), 2006, p2677-80
Brophy K, Ryan AW, Thornton JM, Abuzakouk M, Fitzgerald AP, McLoughlin RM, O'Morain C, Kennedy NP, Stevens FM, Feighery C, Kelleher D, McManus R, Haplotypes in the CTLA4 region are associated with coeliac disease in the Irish population, Genes Immunology, 7, (1), 2006, p19 - 26
Wolters FL, Russel MG, Sijbrandij J, Schouten LJ, Odes S, Riis L, Munkholm P, Langholz E, Bodini P, O'Morain C, Katsanos K, Tsianos E, Vermeire S, Van Zeijl G, Limonard C, Hoie O, Vatn M, Moum B, Stockbrugger RW, The European Collaborative Study Group On Inflammatory Bowel Disease., Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study., Scandinavian Journal of Gastroenterology, May, (243), 2006, p46-54.
Dring MM, Goulding CA, Trimble VI, Keegan D, Ryan AW, Brophy KM, Smyth CM, Keeling PW, O'Donoghue D, O'Sullivan M, O'Morain C, Mahmud N, Wikstrom AC, Kelleher D, McManus R, The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease, Gastroenterology, 130, (2), 2006, p341 - 348
Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, Hommes DW, Lochs H, Angelucci E, Cocco A, Vucelic B, Hildebrand H, Kolacek S, Riis L, Lukas M, de Franchis R, Hamilton M, Jantschek G, Michetti P, O'Morain C, Anwar MM, Freitas JL, Mouzas IA, Baert F, Mitchell R, Hawkey CJ; European Crohn's and Colitis Organisation, European evidence based consensus on the diagnosis and management of Crohn's disease: special situations, Gut, 55, (Supplement 1), 2006, p36 - 58
O'Sullivan M, O'Morain C., Nutrition in inflammatory bowel disease., Best Practice and Research. Clinical Gastroenterology, 20, (3), 2006, p561-73
Cavallaro LG, Egan B, O'Morain C, Di Mario F, Treatment of Helicobacter pylori infection., Helicobacter, 11 Suppl 1, 2006, p36-9
Sebastian S, O'Morain C., Improving surveillance for Barrett's oesophagus: better to be looked over than be overlooked., BMJ., 24, (332(7556)), 2006, p1511-2
McLoughlin RM, O'Morain CA., Colorectal cancer screening., World Journal Gastroenterology, 14;, (12(42):), 2006, p6747-50
Dring MM, Goulding CA, Trimble VI, Keegan D, Ryan AW, Brophy KM, Smyth CM, Keeling PWN, O'Donoghue D, O'Sullivan M, O'Morain C, Mahmud N, Wikström A-C, Kelleher D, McManus R., The Pregnane X Receptor Locus is Associated with susceptibility to inflammatory bowel disease., Gastroenterology, 130, (2), 2006, p341 - 348
Riis L, Vind I, Politi P, Wolters F, Vermeire S, Tsianos E, Freitas J, Mouzas I, Ruiz Ochoa V, O'Morain C, Odes S, Binder V, Moum B, Stockbrugger R, Langholz E, Munkholm P; European Collaborative study group on Inflammatory Bowel Disease., Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease, American Journal Gastroenterology , 101, (7), 2006, p1539-45
Brophy K, Ryan AW, Thornton JM, Daly JS, McLoughlin R, O' Morain C, Abuzakouk M, Kennedy NP, Stevens FM, Feighery C, Kelleher D, McManus R, Haplotypes in the CTLA4 region are associated with coeliac disease in the Irish population., Genes and Immunity, 7, (1), 2006, p19 - 26
O'Morain C, Management and Treatment of Chronic Constipation, Modern Medicine, 36, (1), 2006, p17 - 21
Stolte M, Muller H, Talley NJ, O'morain C, Bolling-Sternevald E, Sundin M, Eriksson S, Blum A., In patients with Helicobacter pylori gastritis and functional dyspepsia, a biopsy from the incisura angularis provides useful diagnostic information., Pathology Research and Practice., 202, (6), 2006, p405-13.
Odes S, Vardi H, Friger M, Wolters F, Russel MG, Riis L, Munkholm P, Politi P, Tsianos E, Clofent J, Vermeire S, Monteiro E, Mouzas I, Fornaciari G, Sijbrandij J, Limonard C, Van Zeijl G, O'morain C, Moum B, Vatn M, Stockbrugger R, Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation., Gastroenterology, 131, (3), 2006, p719-28
Bytzer P, O'Morain C, Treatment of Helicobacter pylori, Helicobacter, 10, (Supplement 1), 2005, p40 - 46
Dong Q, O'Sullivan M, Nami A, Dowling P, Murphy G, Buckley M, O'Morain C., A genetic locus of Helicobacter pylori inversely associated with gastric intestinal metaplasia, Immunology and Medical Microbiology, May 1, (44(2), 2005, p243-9.
Dong Q, O'Sullivan M, Nami A, Dowling P, Murphy G, Buckley M, O'Morain C, A genetic locus of Helicobacter pylori inversely associated with gastric intestinal metaplasia, FEMS Immunol Med Microbiol, 44, (2), 2005, p243 - 249
Megraud F, O'Morain C and the European Paediatric Task Force on Helicobacter pylori, Comparison of Non-Invasive tests to detect Helicobacter Pylori infection in children , The Journal of Pediatrics, 146, 2005, p198 - 203
McLoughlin RM, O'Morain CA, O'Connor HJ, Eradication of Helicobacter pylori: recent advances in treatment, Fundamentals Clinical Pharmacology, 19, (4), 2005, p421 - 427
Ryan AW, Thornton JM, Brophy K, Daly JS, McLoughlin RM, O' Morain C, Abuzakouk M, Kennedy NP, Stevens FM, Feighery C, Kelleher D, McManus R., Chromosome 5q candidate genes in coeliac disease: genetic variation at IL4, IL5, IL9, IL13, IL17B and NR3C1., Tissue Antigens, 65, (2), 2005, p150 - 155
Ryan AW, Thornton JM, Brophy K, Daly JS, McLoughlin RM, O'Morain C, Abuzakouk M, Kennedy NP, Stevens FM, Feighery C, Kelleher D, McManus R., Chromosome 5q candidate genes in coeliac disease: genetic variation at IL4, IL5, IL9, IL13, IL17B and NR3C1., Tissue Antigens, 65, (2), 2005, p150-5
Qasim A, Sebastian S, Thornton O, Dobson M, McLoughlin R, Buckley M, O'Connor H, O'Morain C., "Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.", Aliment Pharmacology Theapeutics, 21, (1), 2005, p91 - 96
Wolters FL, van Zeijl G, Sijbrandij J, Wessels F, O'Morain C, Limonard C, Russel MG, Stockbrugger RW, Internet-based data inclusion in a population-based European collaborative follow-up study of inflammatory bowel disease patients: description of methods used and analysis of factors influencing response rates, World Journal of Gastroenteroogy, 11, (45), 2005, p7152 - 7158
McLoughlin R, O'Morain C, Effectiveness of antiinfectives, Chemotherapy, 51, (5), 2005, p243 - 246
Raghunath AS, O'Morain C, McLoughlin RC, Review of Review article: "the long-term use of proton-pump inhibitors.", Alimentary Pharmacology Therapeutics, 22, (Supplement 1), 2005, p55-63
Dong Q, O'Sullivan M, Nami A, Dowling P, Murphy G, Buckley M, O'Morain C., A genetic locus of Helicobacter pylori inversely associated with gastric intestinal metaplasia, Immunology and Medical Microbiology, May 1, (44(2), 2005, p243-9.
Ryan AW, Thornton JM, Brophy K, Daly JS, McLoughlin RM, O'Morain C, Abuzakouk M, Kennedy NP, Stevens FM, Feighery C, Kelleher D, McManus R, Chromosome 5q candidate genes in coeliac disease: genetic variation at IL4, IL5, IL9, IL13, IL17B and NR3C1., Tissue Antigens., 65, (2), 2005, p150 - 155
Winawer S, Faivre J, Selby J, Bertaro L, Chen TH, Kroborg O, Levin B, Mandel J, O'Morain C, Richards M, Rennert G, Russo A, Saito H, Semigfnovsky B, Wong B, Smith R., "Workgroup II: the screening process. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002)", Annals of Oncology, 16, (1), 2005, p31 - 33
O'Morain C, Helicobacter pylori infection and gastric cancer, British Journal of Surgery, 92, (10), 2005, p1187 - 1188
Bloom S, Kiilerich S, Lassen MR, Forbes A, Leiper K, Langholz E, Irvine EJ, O'Morain C, Lowson D, Orm S., "Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis.", Aliment Pharmacology Therapeutics, 19, (8), 2004, p871-8.
Keighley MR, O'Morain C, Giacosa A, Ashorn M, Burroughs A, Crespi M, Delvaux M, Faivre J, Hagenmuller F, Lamy V, Manger F, Mills HT, Neumann C, Nowak A, Pehrsson A, Smits S, Spencer K; United European Gastroenterology Federation Public Affairs Committee, "Public awareness of risk factors and screening for colorectal cancer in Europe", European Journal of Cancer Preventation , 13, (4), 2004, p257-62
Arnott IDR, Nimmo ER, Drummond HE, Fennell J, Smith BR, MacKinlay E, Morecroft J, Anderson N, O'Sullivan M, O'Morain C, Kelleher D, McManus R, Satsangi J., NOD2/CARD15, TLR4 and CD14 Mutations in Scottish and Irish Patients with Crohn's disease: Evidence for Genetic Heterogeneity within Europe., Genes and Immunity, 5, (5), 2004, p417 - 425
M. O'Sullivan and C. O'Morain, Nutritional Therapy in Inflammatory Bowel Disease, Curr Treat Options Gastroenterol, 7, (3), 2004, p191-198
R. J. Steele, R. Gnauck, R. Hrcka, O. Kronborg, C. Kuntz, P. Moayyedi, C. O'Morain, J. Spicak and H. Vainio, Methods and Economic Considerations: Group 1 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003. fulfillment corporate, Endoscopy, 36, (4), 2004, p349-53
Sebastian S, O'Connor H, O'Morain C, Buckley M., "Argon plasma coagulation as first-line treatment for chronic radiation proctopathy.", Journal of Gastroenterology Hepatology , 19, (10), 2004, p1169-73
Sebastian S, Qasim A, McLoughlin R, O'Morain CA, O'Connor HJ., "Fundic gland polyps: not so trivial entity and worth evaluation.", Gastroenterology, 126, (5), 2004, p1497-1498
A. W. Ryan, J. M. Thornton, K. Brophy, J. S. Daly, C. O'Morain, R. M. McLoughlin, N. P. Kennedy, M. Abuzakouk, F. M. Stevens, C. Feighery, D. Kelleher and R. McManus, Haplotype variation at the IBD5/SLC22A4 locus (5q31) in coeliac disease in the Irish population, Tissue antigens, 64, (2), 2004, p195-8
S. Sebastian, R. McLoughlin, A. Qasim, C. A. O'Morain and M. J. Buckley, Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasia (watermelon stomach): long-term results, Digestive and liver disease, 36, (3), 2004, p212-7
R. McLoughlin, I. Racz, M. Buckley, H. J. O'Connor and C. O'Morain, Therapy of Helicobacter pylori, Helicobacter, 9 Suppl 1, 2004, p42-8
O'Sullivan M, O'Morain C, Nutritional Therapy in Inflammatory Bowel Disease, Current Treatment Options Gastroenterology, 7, (3), 2004, p191 - 198
Bonithon-Kopp C, Piard F, Fenger C, Cabeza E, O'Morain C, Kronborg O, Faivre J, European Cancer Preventation Organisation Study Group, Colorectal adenoma characteristics as predictors of recurrence, Diseases of the Colon and Rectum, 47, (3), 2004, p323 - 333
Qasim A, Shirley R, O'Morain C, Entral and parenteral therapy in inflammatory bowel disease, Annals of Gastroenterolog, 17, (4), 2004, p346 - 353
Qasim A, Sebastian S, Buckley M, O'Connor H, O'Morain C, "Pretreatment antimicrobial susceptibility testing is not cost saving in the standard eradication of Helicobacter pylori.", Clinical Gastroenterology Hepatology, 2(1):, (85), 2004, 85.
S. Sebastian, H. O'Connor, C. O'Morain and M. Buckley, Argon plasma coagulation as first-line treatment for chronic radiation proctopathy, Journal of Gastroenterology Hepatology, 19, (10), 2004, p1169-1173
C. Bonithon-Kopp, F. Piard, C. Fenger, E. Cabeza, C. O'Morain, O. Kronborg and J. Faivre, Colorectal adenoma characteristics as predictors of recurrence, Diseases of the colon and rectum, 47, (3), 2004, p323-33
Ryan AW, Thornton JM, Brophy K, Daly JS, O' Morain C, McLoughlin RM, Kennedy NP, Abuzakouk M, Stevens FM, Feighery C, Kelleher D, McManus R. , Haplotype variation at the IBD5 locus (5q31) in coeliac disease in the Irish population. , Tissue Antigens, 64, (2), 2004, p195 - 198
Sebastian S, O'Morain CA, Buckley MJ, "Current therapeutic options for gastric antral vascular ectasia", Aliment Pharmacology Therapeutics, 15, (18(2): ), 2003, p157-65
D. Mc Namara, W. Hall, M. O'Sullivan and C. O'Morain, Altered cardia epithelial cell kinetics induced by Helicobacter pylori infection and gastro-oesophageal reflux disease: possible malignant potential?, European journal of gastroenterology & hepatology, 15, (7), 2003, p767-72
Xia HH, Talley NJ, Blum AL, O'Morain CA, Stolte M, Bolling-Sternevald E, Mitchell HM, "Clinical and pathological implications of IgG antibody responses to Helicobacter pylori and its virulence factors in non-ulcer dyspepsia.", Alimentary Pharmacology Therapeutics, 1, (17(7)), 2003, p935-43
Zouali H, Lesage S, Merlin F, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, Christensen S, Finkel Y, Modigliani R, Gower-Rousseau C, "Marcy J, Chamaillard M, Thomas G, Hugot JP., CARD4/NOD1 is not involved in inflammatory bowel disease., Gut, 52, (1), 2003, p71-4
McDonnell R, O'Morain C, Boland M, Culhane A, Johnson Z, Johnson A, Murray F, Doyle D, "Helicobacter pylori eradication theraphy: getting research into practice.", Irish Medical Journal, 96, (1), 2003, p13-6
McLoughlin RM, Sebastian SS, O'Connor HJ, Buckley M, O'Morain CA, "Test and treat or test and scope for Helicobacter pylori infection. Any change in gastric cancer prevention?", Aliment Pharmacology Therapeutics, 17, (2), 2003, p82-8
Perri F, Qasim A, Marras L, O'Morain C, "Treatment of Helicobacter infection", Helicobacter, 18, (Supp 3:), 2003, p45-8
Goh J, O'Morain C, "Nutrition and adult inflammatory bowel disease.", Alimentary Pharmacology Therapeutics, 17, (3), 2003, p307-20
Xia HH, Talley NJ, Blum AL, O'Morain CA, Stolte M, Bolling-Sternevald E, Mitchell HM, "Clinical and pathological implications of IgG antibody responses to Helicobacter pylori and its virulence factors in non-ulcer dyspepsia.", Aliment Pharmacology and Therapeutics, 1, (17(7):), 2003, p935-43
McLoughlin R, Sebastian SS, Qasim A, McNamara D, O'Connor HJ, Buckley M, O'Morain C, "Coeliac disease in Europe", Aliment Pharmacology Therapeutics, 18,, (3), 2003, p45-8
C. O'Morain, T. Borody, A. Farley, W. A. De Boer, C. Dallaire, R. Schuman, J. Piotrowski, C. A. Fallone, G. Tytgat, F. Megraud and J. Spenard, Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study, Alimentary pharmacology & therapeutics, 17, (3), 2003, p415-20
O'Sullivan M, O'Morain C, "Food Intolerance: Dietary Treatments in Functional Bowel Disorders.", Current Treatment Options in Gastroenterology, 6, (4), 2003, p339-345
Sebastian S, Serry J, O'Morain C, Buckley M, "Endoscopic surveillance of premalignant gastric lesions.", Gut, 52, (1), 2003, p152-3
W. Hall, M. Buckley, P. Crotty and C. A. O'Morain, Gastric mucosal mast cells are increased in Helicobacter pylori-negative functional dyspepsia, Clin Gastroenterol Hepatol, 1, (5), 2003, p363-9
S. S. Sebastian, N. Kernan, A. Qasim, C. A. O'Morain and M. Buckley, Appropriateness of gastric antisecretory therapy in hospital practice, Irish journal of medical science, 172, (3), 2003, p115-7
E. Bairead, D. L. Harmon, A. M. Curtis, Y. Kelly, C. O'Leary, M. Gardner, D. T. Leahy, P. Vaughan, D. Keegan, C. O'Morain, D. O'Donoghue, F. Shanahan, N. A. Parfrey and K. A. Quane, Association of NOD2 with Crohn's disease in a homogenous Irish population, European journal of human genetics, 11, (3), 2003, p237-44
Gastric urease in ulcer patients in the 1940's: The Irish connection in, editor(s) Barry Marshall , Helicobacter Pioneers, Blackwell Science Asia Pty Ltd , 2002, pp29-38 , [O'Connor H.J., O'Morain C.A]
Edited by: DA Christie, E M Tansey, The Welcome Trust , WELLCOME WITNESSES TO TWENITH CENTURY MEDICINE PEPTIC ULCER: RISE AND FALL, Volume 14, Witness Seminar Transcript, 2002, 33, 90-93, 94, 119pp
Helicobacter amalgamates inflammatory bowel disease in, editor(s)Shimoyama T, Axon A, Lee A, Podolsky DK, O'Morain C , Helicobacter meets inflammatory bowel disease, Tokyo, Medical Tribune, 2002, pp485-493 , [O'Morain CA]
A. M. Hopkins, C. McDonnell, N. P. Breslin, C. A. O'Morain and A. W. Baird, Omeprazole increases permeability across isolated rat gastric mucosa pre-treated with an acid secretagogue, The Journal of pharmacy and pharmacology, 54, (3), 2002, p341-7
Eds: Shimoyana T, Lee A, Axon A, Podolsky PK, O'Morain C., HELICOBACTER MEETS INFLAMMATORY BOWEL DISEASE International workshop on mucosal inflammation and cytokines , , Japan, Medical Tribune Inc., 2002
Dinan TG, Mahmud N, Rathore O, Thakore J, Scott L V, Carr E, Naesdal J, O'Morain CA, Keeling PW., A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia - are central serotoninergic responses enhanced?, Aliment Pharmacol Ther, 15, (10), 2001, p1613-8
Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G, Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease., Nature , 31, (411), 2001, p599-603
N. Mahmud, M. A. Kamm, J. L. Dupas, D. P. Jewell, C. A. O'Morain, D. G. Weir and D. Kelleher, Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study, Gut, 49, (4), 2001, p552-6
Dong Q., Hyde D., Herra C., Kean C., Murphy P., O'Morain C.,Buckley M, Identification of genes regulated by prolonged acid exposure in Helicobacter pylori., FEMS Microbiology Letters, 15, (196(2)), 2001, p249-249
O'Sullivan M, O'Morain C, Liquid diets for Crohn's disease., Gut , 48, 2001, p757
Mahmud N, Kamm MA, Dupas JL, Jewell DP, O'Morian CA, Weir DG, Kelleher D, Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind parallel, randomised, multicentre study., Gut, 49, (4), 2001, p552-6
Daly B. and O' Morain C, Management of dyspepsia, Current Opinion in Gastroenterology, 17, (suppl 1), 2001, pS38-S42
O'Sullivan M., O'Morain C., Nutritional Treatments in Inflammatory Bowel Disease., Current Treatments Options in Gastroenterology, 4, 2001, p207-213
O'Sullivan M, O'Morain C , Patient knowledge in inflammatory bowel disease., Am J Gastroenterol, 95, 2000, p2128-9
O'Sullivan MA, O'Morain CA , Bacterial supplementation in the irritable bowel syndrome - a randomised double blind placebo-controlled crossover study. , Digest & Liver Disease, 32, 2000, p294-301
Dundon WG, Marshall DG, O'Morain CA, Smyth CJ , Population characteristics of Irish Helicobacter pylori isolates: a tRNA-associated locus., Ir J Med Sci, 169, (2), 2000, p137-40
Barr M., Buckley M., O'Morain C. , Non-sterodial anti-inflammatory drugs and Helicobacter pylori, Aliment Pharmacol Ther, 14, 2000, p43-47
Lacy PD, Lee JM, O'Morain CA, Temporomandibular joint dislocation: an unusual compliaction of upper gastrointestinal endoscopy., Am J Gastroenterol , 95, 2000, p3653-4
Ryan KA, Moran AP, Hynes SO, Smith T, Hyde D, O'Morain CA, Maher M, Genotyping of cagA and vacA, Lewis antigen status, and analysis of the poly-(C) tract in the alpha(1,3)-fucosyltransferase gene of Irish Helicobacter pylori isolates., Immunol Med Microbiol , 28, 2000, p113-20
McNamara D, O'Morain C, Non-ulcer dyspepsia: Current concepts and management., Gastroenterology Clinics of North America , 29, 2000, p807-18
O'Morain C., Montague S. , Challenges to Therapy in the Future., Helicobcater, 5, (1), 2000, pS23-S26
Breslin NP, Lee JM, Buckley MJ, Balbirnie E, Rice D, O'Morain CA , Validation of serological tests for Helicobacter pylori infection in an Irish Population., Irish J Med Sci, 169, 2000, p190-4
McNamara D, Buckley M, O'Morain C, Will eradication of Helicobacter pylori improve symptoms of non-ulcer dyspepsia. More studies should have been included in the meta-analysis., British Medical Journal , 29, (320 (7243):), 2000, p1209-10
Lee JM, Breslin NP, Gopaul M, Koh CW, Kong TY, Soong MM, , The effects of blood on rapid urease testing for Helicobacter pylori in mucosal biopsies from the gastric antrum., Irish Journal Medical Science, 169, 2000, p60-62
Vaira D., Malfertheiner P.,. Megraud F, Axon A., Deltenre M., Gasbarrini G.. O'Morain C., Pajares Garcia J., Quina M., Tytgat G., and the European Helicobacter pylori HpSA Study Group., Noninvasive Antigen-Based Assay for Assessing Helicobacter pylori Readication: A European Multicenter Study., American Journal of Gastroenterology, 95, 2000, p925-929
M. O'Sullivan, N. Clayton, N. P. Breslin, I. Harman, C. Bountra, A. McLaren and C. A. O'Morain, Increased mast cells in the irritable bowel syndrome, Neurogastroenterol Motil, 12, (5), 2000, p449-57
Megraud F, Burette A, Clupczynski Y, Fiocca R, Logan R, Quina M, Ericsson S, O'Morain C, Comparison of tests for assessment of Helicobacter pylori eradication: results of a multi-centre study using centralized facility testing., Eur J Gastroenterol Hepatol, 12, (6), 2000, p629-33
Bazzoli F, Graham D.Y., Holtmann G., McColl K., O'Morain C., Sung J.J., Panel discussion - unresolved issues., Helicobacter, 5, 2000, p27-31
O'Sullivan M, Lovette E, Mahmud N, O'Morain CA, Educational needs in patients knowledge in patients with irritable bowel syndrome (IBS)., Eur J of Gastroenterology & Hepatology , 11, 2000, p1-5
O'Sullivan, M.A. O'Morain C.A, Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study., Digest Liver Dis, 32, 2000, p294-301
Lee JM, Breslin NP, Gopaul M, Koh CW, Kong TY, Soong MM, , The effects of blood on rapid urease testing for Helicobacter pylori in mucosal biopsies from the gastric antrum., Ir J Med Sci, 169, (1), 2000, p60-2
Lee J, Deasy E., O'Morain C.A., Helicobacter pylori eradication therapy: a discrepancy between current guidelines and clinical practice., Eur J of Gastro & Hepatol, 12, 2000, p433-437
J. M. Lee, N. P. Breslin, C. Fallon and C. A. O'Morain, Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding, The American journal of gastroenterology, 95, (5), 2000, p1166-70
M. A. O'Sullivan, N. Mahmud, D. P. Kelleher, E. Lovett and C. A. O'Morain, Patient knowledge and educational needs in irritable bowel syndrome, European journal of gastroenterology & hepatology, 12, (1), 2000, p39-43
Vaira D, Malfertheiner P, Megraud F, Axon ATR, Deltenre M, Gasbarrini G, O'Morain C, Pajares Garcia JM, Quina M, Tytgat GNJ and European Helicobacter HpSA Study Group. , Non-invasive antigen based assay for assessing Helicobacter pylori eradication. A multi-centre study. , Am J Gastroenterol, 95, 2000, p925-929
M. J. Quinn, J. B. Foley, N. T. Mulvihill, J. Lee, P. A. Crean, M. J. Walsh and C. A. O'Morain, Helicobacter pylori serology in patients with angiographically documented coronary artery disease, The American journal of cardiology, 83, (12), 1999, p1664-6, A6
McNamara D, O'Morain C. , Gastroesophageal reflux disease and Helicobacter pylori: an intricate relation. , Gut, 45, 1999, pI13-17
Quinn MJ, Foley JB, Mulvihill NT, Lee J, Crean PA, Walsh MJ, , Helicobacter pylori serology in patients with angiographically documented coronary artery disease., American Journal of Cardiology, 15, (83(12):,6), 1999, p1664-6
Vaira D, Malfertheiner P, Megraud F, Axon ATR, Deltenre M, Hirschl AM, Gasbarrini G, O'Morain CA, Pajares Garcia JM, Quina M, Tygat GNJ, and the HpSA European Study Group., Diagnosis of Helicobacter pylori infection with a new non invasive antigen based assay., The Lancet, 354, (9172), 1999, p30-33.
McNamara D, O'Morain C, GERD and Helicobacter pylori: an intricate relationship, Gut , 45, (Suppl.1), 1999, p113 - 117
Lee JM, McNamara D, Breslin NP, Hyde DK, O'Morain C, Options for Helicobacter eradication in clinical practice when proton pump inhibitor-based triple therapy fails, Gut , 41, (Suppl.3), 1997, pA16
M. Buckley, A. Culhane, B. Drumm, C. Keane, A. P. Moran, H. J. O'Connor, J. Collins, D. Kelleher, D. McAvinchey, J. Sloan and C. O'Morain, Guidelines for the management of Helicobacter pylori-related upper gastrointestinal diseases. Irish Helicobacter Pylori Study Group, Irish journal of medical science, 165 Suppl 5, 1996, p01-Nov
H. X. Xia, H. J. Windle, D. G. Marshall, C. J. Smyth, C. T. Keane and C. A. O'Morain, Recrudescence of Helicobacter pylori after apparently successful eradication: novel application of randomly amplified polymorphic DNA fingerprinting, Gut, 37, (1), 1995, p30-Apr
Non-Peer-Reviewed Publications
xxx, xxx, 2018
xxx, xxx, 2018
Research Expertise
Description
Autism. Pathogenesis of Helicobacter infectionRecognition
Representations
Invitee, Colorectal & GI Cancer Research Group (Proposed), Speculative idea to cluster PI's around collaborative study on Upper GI and Colon Cancers.Deliberately wide selection of surgeons, pathologists and academic researchers based on stated interest or publication in fields of oesophageal or colorectal cancer.To be reviewed/focused by DK/JR/PMacM.Extracted from DMMC Research Database - 8 Nov 2004.